Strongbridge Biopharma plc
Pharmaceutical company · Trevose, Pennsylvania, United States
Strongbridge Biopharma plc is a pharmaceutical company headquartered in Trevose, Pennsylvania, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $35 million sold in a notice filed in 2016.
Strongbridge Biopharma at a glance
What does Strongbridge Biopharma do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $35 million sold (2016).
Frequently asked questions about Strongbridge Biopharma
Where is Strongbridge Biopharma headquartered?
Strongbridge Biopharma plc is headquartered in Trevose, Pennsylvania, United States.
What does Strongbridge Biopharma do?
Strongbridge Biopharma plc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Strongbridge Biopharma founded?
The earliest incorporation on record for Strongbridge Biopharma plc is in 2015, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences